PharmAthene Completes Dosing in Valortim® Phase I Clin... ( ANNAPOLIS Md. April 13 2011 /- PharmA...)

PharmAthene Completes Dosing in Valortim® Phase I Clinical Trial

Date:4/13/2011

ANNAPOLIS, Md., April 13, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP) announced today that it has completed dosing in a U.S. Phase I clinical trial of its fully human anti-toxin monoclonal antibody, Valortim®, being developed for the prevention and treatment of inhalational anthrax.

The randomized, placebo-controlled, double-blind Phase I clinical trial was designed to evaluate single escalating doses of 1, 5, or 10 mg/kg of Valortim® (or placebo) administered intravenously over a 120 minute infusion period. A total of 28 participants, all healthy male and female volunteers between the ages of 18 and 60 years, were enrolled in the study.

"We have completed dosing of all 28 subjects and are pleased to report that no infusion-related adverse reactions have been observed in the current Phase I trial. We anticipate that safety follow-up will be completed in the third quarter of 2011 with final unblinded results available later in the year," remarked Dr. Thomas Fuerst, Executive Vice President and Chief Scientific Officer.

"This represents an important step in the development of Valortim®, which is being developed to meet the criteria for stockpiling in the U.S. Strategic National Stockpile," continued Dr. Fuerst. "In preclinical animal studies Valortim® has been shown to protect both rabbits and monkeys against the lethal effects of anthrax infection when administered at the time of exposure, at doses as low as 1.0 mg/kg. When administered to rabbits after the development of symptoms, Valortim® also improved survival as late as 48 hours post-exposure as compared to control animals. We look forward to completing the Phase I clinical trial, which will provide important information about the IV dosing schedule for Valortim® in humans."

The Valortim® project has been conducted with
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
2. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
3. PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
4. PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
5. PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program
6. PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
7. PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
8. PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop
9. PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop
10. PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health
11. PharmAthene Presents New Data for Lyophilized rPA Anthrax Vaccine Showing Enhanced Immunogenicity

Post Your Comments:

(Date:5/21/2013)... (NASDAQ: LCAV ), a leading provider of laser ... that all nominees to the company,s Board of Directors were ... These Directors are: , William F. Bahl ... Counsel , John C. Hassan , ... Heizer III , Chairman of Manus Health Systems, Inc. ...

(Date:5/21/2013)... PHILADELPHIA , May 21, 2013 ... and impressive new product developments at the Special Libraries Association ... years of unerring focus on product literature databases and workflow ... mark the occasion," said founding director Nigel Johnson ... developments of benefit to our clients and what better forum ...

(Date:5/21/2013)... , May 21, 2013 Kepner-Tregoe (KT), ... announced that 13-year veteran Chris Geraghty ... Geraghty,s experience includes more than 20 years serving ... with manufacturing organizations. He succeeds Ray ... as Kepner-Tregoe,s Chairman of the Board and CEO. ...

Breaking Medicine Technology:LCA-Vision Reports on Annual Meeting of Stockholders 2 LCA-Vision Reports on Annual Meeting of Stockholders 3 LCA-Vision Reports on Annual Meeting of Stockholders 4 Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2 Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3 Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2 Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3

[0] LCA-Vision Reports on Annual Meeting of Stockholders [0] Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia [0] Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer

... YORK, Oct. 31 Crystal Research,Associates, LLC ... Executive,Informational Overview(R) (EIO(R)) on CEL-SCI Corporation (Amex: ... be found at http://www.crystalra.com . ... disease,therapies. Its primary product candidate is Multikine(R), ...

... Group,s Anti-Meat Bias, Stand,in Sharp Contrast to U.S. ... Oct. 31 The American Meat,Institute (AMI) today ... limit red and processed meat intake to extremely ... be met with,skepticism because they oversimplify the complex ...

Cached Medicine Technology:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation 2 Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation 3 American Meat Institute Calls WCRF Panel Recommendations on Meat Consumption Extreme and Unfounded 2 American Meat Institute Calls WCRF Panel Recommendations on Meat Consumption Extreme and Unfounded 3 American Meat Institute Calls WCRF Panel Recommendations on Meat Consumption Extreme and Unfounded 4

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation American Meat Institute Calls WCRF Panel Recommendations on Meat Consumption Extreme and Unfounded

(Date:5/21/2013)... In adults with chronic kidney disease (CKD), ... CKD progression and transplant failure. Now, a first-of-its-kind study ... University has found a possible similar effect in children ... , The study of 366 children aged 1 ... effect of secondhand smoke exposure in CKD, according to ...

(Date:5/21/2013)... By Amy Norton HealthDay Reporter , , TUESDAY, ... alterations in two genes may be at increased risk ... study suggests. The researchers hope they can use ... help spot pregnant women who are vulnerable to postpartum ... Their study, reported in the May 21 issue ...

(Date:5/21/2013)... 21 (HealthDay News) -- When a classmate commits suicide, ... themselves, according to a new study. This "suicide contagion" ... student personally, the researchers found. Teens aged 12 ... by Dr. Ian Colman, Canada Research Chair in Mental ... of Public Health. The study appeared May 21 in ...

(Date:5/21/2013)... Bronson Gray HealthDay Reporter , , TUESDAY, May ... cancer was once next to impossible, but a new ... that screening with low-dose CT scans may help spot ... Among patients considered at the greatest risk for lung ... after getting CT scans and follow-up biopsies to confirm ...

(Date:5/21/2013)... The Special Olympics Missouri State Summer Games ... the state to Columbia. This state-level event takes place May ... and Columbia College, and at Hickman High School and Town ... kick off at 7:30 p.m. Friday, May 30 with the ... theme, the Parade of Athletes, the culmination of the statewide ...

Breaking Medicine News(10 mins):Health News:Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study 2 Health News:Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study 3 Health News:Genes May Boost Woman's Risk of Postpartum Depression 2 Health News:Genes May Boost Woman's Risk of Postpartum Depression 3 Health News:Student Suicide May Spur Similar Thoughts in Teens 2 Health News:Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer 2 Health News:Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer 3 Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 2 Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 3

[0] Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study [0] Genes May Boost Woman's Risk of Postpartum Depression [0] Student Suicide May Spur Similar Thoughts in Teens [0] Study Supports Using Low-Dose CT Scans to Spot Early Lung Cancer [0] Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia

... Associates, LLC,announced today that it has issued an ... Board: BOCX). The full 52-page,report can be found ... or "the Company") is a biotechnology company,developing products ... global oncology market forecast to reach over $50 ...

... Establishes Effects of Puzzle ... and Word Games on the Human Body and Mind, ... Carolina,University,s Department of Recreation and Leisure Studies today revealed,the ... measured,the stress-relieving and other mood-lifting effects of so-called "casual",video ...

... of the major side effects of pain therapy for ... Food and Drug Administration on April 24, 2008, for ... patients receiving palliative care for advanced illness such as ... for Medicinal Products for Human Use, also rendered a ...

... Company -, LAVAL, QC, April 28 /PRNewswire-FirstCall/ ... that Claire Brulle, M.D. has been appointed,Senior Vice-President ... Medical Officer Dr. Sylvie Bouchard has retired from ... "Dr. Brulle brings to Labopharm a proven ...

... 1,440 Stores in May 2008, NEW YORK ... medical,device company publicly traded on the Tel Aviv ... hypertension treatment device,clinically-proven to significantly lower blood pressure, ... Kingdom this May through,Lloyds Pharmacy, the leading community ...

... 28 Readers in Europe and other parts of,the ... debut book,from London-born author Shireen Jeejeebhoy. It tells the ... medical history as the first,person to live long-term strictly ... has just scooped awards in the US for Editor,s ...

Cached Medicine News:Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc. 2 Health News:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc. 3 Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 2 Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 3 Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 4 Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 5 Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 6 Health News:Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted 7 Health News:Drug developed at the University of Chicago wins FDA approval 2 Health News:Drug developed at the University of Chicago wins FDA approval 3 Health News:Drug developed at the University of Chicago wins FDA approval 4 Health News:Labopharm Appoints Dr. Claire Brulle as Senior Vice-President and Chief Medical Officer 2 Health News:InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group 2 Health News:InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group 3 Health News:InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group 4 Health News:Story of Woman's Courage and Medical Innovation Top Choice for Readers 2

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc.Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted Drug developed at the University of Chicago wins FDA approval Labopharm Appoints Dr. Claire Brulle as Senior Vice-President and Chief Medical Officer InterCure Secures Nationwide Distribution Agreement With Lloyds Pharmacy Group Story of Woman's Courage and Medical Innovation Top Choice for Readers

... For maximum productivity, and proven ... a compact, fully automatic cell washing ... a fast 80-second wash cycle for ... touch controls, and standardized, reproducible procedures. ...

Excellent all-around performance in digital format - MIC-D offers an exciting new way to observe the natural world. Multiple performance features provide new ways to enjoy microscope observation....

... refrigerated floor model centrifuge. High throughput, ... full speed with all windshield rotors, ... collected at a remote personal computer ... include automatic imbalance detection and shut ...

... low speed refrigerated centrifuge. Instant rotor ... patented system, comprehensive control using VIDEOset ... individual password protection of programs, 10 ... run profiles), powerful refrigeration 4C or ...

Medicine Products:

CW-2 Cell Washing System MIC-D Digital Microscope KR 4.22 Programmable Refrigerated Floor Model Centrifuge.MR 23 Multi-Function Programmable High and Low Speed Refrigerated Centrifuge.